$150.33

-1.32%

MRK

Merck & Company, Inc.

•Healthcare

Mega-Cap Pharma

Oncology Leader

Dividend Payer

Institutional Favorite

Mega-Cap Pharma

Oncology Leader

Dividend Payer

Institutional Favorite

Loading Chart...

FIT ANALYSIS

Required for personalization

FIT ANALYSIS

Checking Membership...

STOCK DNA

Valuation

4/10

Quality

3/10

Growth

7/10

Strength

6/10

Dividend

4/10

Similar Stocks

BMY Bristol-Myers Squibb Company

JNJ Johnson & Johnson

LLY Eli Lilly and Company

NVS Novartis AG

PFE Pfizer, Inc.

Health Indicators

Price Trend

Upwards

Momentum

Stretched

Balance Sheet

Moderate

Earnings

Growth

Dividend Yield

2.23%

Market Cap

$370.89B

TALK TO YOUR STOCK

EQUITAI ASSISTANT

Merck is a global pharmaceutical leader that develops prescription medicines, vaccines, and biologic therapies. Its primary focus is on advancing treatments in oncology, infectious diseases, and cardio-metabolic disorders. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.

Talk to Your Stock•open live chat

Pro EquitAI Research

Retrieving premium status...